Does FEZOLINETANT Cause Therapy cessation? 7 Reports in FDA Database
Thyroid Balance & Feminine Wellness
Thyrafemme Balance — 14 gentle ingredients for energy, mood & hormonal harmony.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Therapy cessation have been filed in association with FEZOLINETANT (VEOZAH). This represents 0.5% of all adverse event reports for FEZOLINETANT.
7
Reports of Therapy cessation with FEZOLINETANT
0.5%
of all FEZOLINETANT reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy cessation From FEZOLINETANT?
Of the 7 reports, and 1 (14.3%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FEZOLINETANT. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does FEZOLINETANT Cause?
Drug ineffective (184)
Alanine aminotransferase increased (139)
Hepatic enzyme increased (129)
Aspartate aminotransferase increased (104)
Off label use (84)
Headache (78)
Hot flush (77)
Insomnia (75)
Liver function test increased (70)
Nausea (65)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which FEZOLINETANT Alternatives Have Lower Therapy cessation Risk?
FEZOLINETANT vs FIBRINOGEN HUMAN
FEZOLINETANT vs FIBRINOGEN HUMAN\HUMAN THROMBIN
FEZOLINETANT vs FIBRINOGEN HUMAN\THROMBIN HUMAN
FEZOLINETANT vs FIDAXOMICIN
FEZOLINETANT vs FILGOTINIB